Jounce Therapeutics

URI: https://gptkb.org/entity/Jounce_Therapeutics
GPTKB entity
Statements (23)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Redx_Pharma
gptkbp:acquisitionYear 2023
gptkbp:collaboratedWith gptkb:Celgene
gptkbp:focusesOn gptkb:cancer
immunotherapy
gptkbp:foundedYear 2013
gptkbp:founder gptkb:James_Allison
gptkb:Padmanee_Sharma
gptkb:Robert_Schreiber
gptkb:Deborah_Law
gptkb:Louis_Matis
gptkbp:headquartersLocation gptkb:Cambridge,_Massachusetts,_United_States
https://www.w3.org/2000/01/rdf-schema#label Jounce Therapeutics
gptkbp:industry gptkb:biotechnology
gptkbp:notableProduct gptkb:JTX-2011
gptkb:JTX-8064
gptkb:vopratelimab
gptkbp:publiclyTraded yes
gptkbp:stockExchange gptkb:NASDAQ
gptkbp:stockSymbol gptkb:JNCE
gptkbp:bfsParent gptkb:Third_Rock_Ventures
gptkbp:bfsLayer 6